While it is conceivable that tumor-derived growth factors or cytokines may be able to modulate the TME, it remains incompletely understood how SCCs harboring genetic alterations in both TP53 and PIK3CA drive the expansion of TAMs. Here, TP53 is linked to neoplasm.